Functional Consequences of APO-1/Fas (CD95) Antigen Expression by Normal and Neoplastic Hematopoietic Cells

References

• Mizel S.B. The interleukins. FASEB J. 1989; 3: 2379–2388
   PubMed Web of Science ®Google Scholar
• Quesniaux V. F. J. Interleukins 9, 10, 11 and 12 and kit ligand: a brief overview. Res. Immunol. 1992; 143: 385–400
   PubMedGoogle Scholar
• Clark S.C., Kamen R. The human hematopoietic colony-stimulating factors. Science 1987; 236: 1229–1237
   PubMed Web of Science ®Google Scholar
• Groopman J.E., Molina J.-M., Scadden D.T. Hematopoietic growth factors: biology and clinical applications. N. Engl. J. Med. 1989; 321: 1449–1459
   PubMed Web of Science ®Google Scholar
• Cohen J.J., Duke R.C. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 1992; 10: 267–293
   PubMed Web of Science ®Google Scholar
• Koury M.J. Programmed cell death (apoptosis) in hematopoiesis. Exp. Hematol. 1992; 20: 391–394
   PubMed Web of Science ®Google Scholar
• Korsmeyer S.J. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879–886
   PubMed Web of Science ®Google Scholar
• Shaw P., Bovey R., Tardy S., Sahli R., Sordat B., Costa J. Induction of apoptosis by wild-type pS3 in a human colon tumor-derived cell line. Proc. Natl. Acad. Set. USA 1992; 89: 4495–4499
   PubMed Web of Science ®Google Scholar
• Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345–347
   PubMed Web of Science ®Google Scholar
• Mallett S., Barclay A.N. A new superfamily of cell surface proteins related to the nerve growth factor receptor. Immunol. Today 1991; 12: 220–223
   PubMedGoogle Scholar
• Foxwell B. M. J., Barrett K., Feldmann M. Cytokine receptors: structure and signal transduction. Clin. Exp. Immunol. 1992; 90: 161–169
   PubMed Web of Science ®Google Scholar
• Trauth B.C., Klas C., Peters A. M. J., Matzku S., Moller P., Falk W., Debatin K.-M., Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989; 245: 301–305
   PubMed Web of Science ®Google Scholar
• Owen-Schaub L.B., Yonehara S., Crump W.L., Grimm E.A. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 1992; 140: 197–205
   PubMed Web of Science ®Google Scholar
• Debatin K.-M., Goldmann C.K., Bamford R., Waldmann T.A., Krammer P.H. Monoclonal-antibody-mediated apoptosis in adult T-cell leukaemia. Lancet 1990; 335: 497–500
   PubMed Web of Science ®Google Scholar
• Kobayashi N., Hamamoto Y., Hamamoto N., Ishii A., Yonehara M., Yonehara S. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA 1990; 87: 9620–9624
   PubMed Web of Science ®Google Scholar
• Falk M.H., Trauth B.C., Debatin K.-M., Klas C., Gregory C.D., Rickinson A.B., Calender A., Lenoir G.M., Ellwart J.W., Krammer P.H., Bomkamm G.W. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 1992; 79: 3300–3306
   PubMed Web of Science ®Google Scholar
• Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor to tumor necrosis factor. J. Exp. Med 1989; 169: 1747–1756
   PubMed Web of Science ®Google Scholar
• Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S.-I., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243
   PubMed Web of Science ®Google Scholar
• Watanabe-Fukunaga R., Brannan C.I., Copeland N.G., Jenkins N.A., Nagata S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356: 314–317
   PubMed Web of Science ®Google Scholar
• Robertson M.J., Manley T.J., Donahue C., Levine H., Ritz J. Costimulatory signals are required for optimal proliferation of human natural killer cells. J. Immunol. 1993; 150: 1705–1714
   PubMed Web of Science ®Google Scholar
• Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
   PubMed Web of Science ®Google Scholar
• Harlow E., Lane D. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1988
   Google Scholar
• Kombluth J., Flomenberg N., Dupont B. Cell surface phenotype of a cloned line of human natural killer cells. J. Immunol. 1982; 129: 2831–2837
   PubMed Web of Science ®Google Scholar
• Yodoi J., Teshigawara K., Nikaido T., Fukui K., Noma T., Honjo T., Takigawa M., Sasaki M., Minato N., Tsudo M., Uchiyama T., Maeda M. TCGF (IL 2)-receptor inducing factor(s): I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J. Immunol. 1985; 134: 1623–1630
   PubMed Web of Science ®Google Scholar
• Hercend T., Meuer S., Reinherz E.L., Schlossman S.F., Ritz J. Generation of a cloned NK cell line derived from the “null cell” fraction of human peripheral blood. J. Immunol. 1982; 129: 1299–1305
   PubMed Web of Science ®Google Scholar
• Hurwitz R., Hozier J., Le Bien T., Minowada J., Gajl-Peczalska K., Kubonishi I., Kersey J. Characterization of a leukemic cell line of the pre-B phenotype. Int. J. Cancer 1979; 23: 174–180
   PubMed Web of Science ®Google Scholar
• Robertson M.J., Caligiuri M.A., Manley T.J., Levine H., Ritz J. Human natural killer cell adhesion molecules: differential expression after activation and participation in cytolysis. J. Immunol. 1990; 145: 3194–3201
   PubMed Web of Science ®Google Scholar
• Michon J.M., Caligiuri M.A., Hazanow S.M., Levine H., Schlossman S.F., Ritz J. Induction of natural killer effectors from human thymus with recombinant IL-2. J. Immunol. 1988; 140: 3660–3667
   PubMed Web of Science ®Google Scholar
• Oda A., Daley J.F., Kang J., Smith M., Ware J.A., Salzman E.W. Quasi-simultaneous measurement of ionized calcium and α-granule release in individual platelets. Am. J. Physiol 1991; 260: C242–C248, Cell Physiol. 29
   PubMed Web of Science ®Google Scholar
• Robertson M.J., Soiffer R.J., Wolf S.F., Manley T.J., Donahue C., Young D., Herrmann S.H., Ritz J. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells is differentially regulated by NKSF. J. Exp. Med. 1992; 175: 779–788
   PubMed Web of Science ®Google Scholar
• Caligiuri M.A., Zmuidzinas A., Manley T.J., Levine H., Smith K.A., Ritz J. Functional consequences of interleukin 2 receptor expression on resting human lymphocytes: identification of a novel natural killer cell subset with high affinity receptors. J. Exp. Med. 1990; 171: 1509–1526
   PubMed Web of Science ®Google Scholar
• Morimoto C., Reinherz E.L., Borel Y., Schlossman S.F. Direct demonstration of the human suppressor inducer subset by anti-T cell antibodies. J. Immunol. 1983; 130: 157–161
   PubMed Web of Science ®Google Scholar
• Tian Q., Streuli M., Saito H., Schlossman S.F., Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 1991; 67: 629–639
   PubMed Web of Science ®Google Scholar
• Gribben J.G., Freedman A.S., Woo S.D., Blake K., Shu R.S., Freeman G., Longtine J.A., Pinkus G.S., Nadler L.M. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 1991; 78: 3275–3280
   PubMed Web of Science ®Google Scholar
• Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., Li-Weber M., Richards S., Dhein J., Trauth B.C., Ponstingl H., Krammer P.H. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor family: sequence identity with the Fas antigen. J. Biol. Chem. 1992; 267: 10709–10715
   PubMed Web of Science ®Google Scholar
• Robertson M.J., Ritz J. Cluster report: CD95. Leukocyte Typing V: White Cell Differentiation Antigens, S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R.L. Silverstein, T.A. Springer, T.F. Tedder, R.F. Todd. Oxford University Press, Oxford 1994, (In press)
   Google Scholar
• Yonehara S., Nishimura Y., Kishi S., Ishii A. Expression and function of apoptosis antigen Fas on T cells in the thymus and periphery. Tissue Antigens 1993; 42: 253, (abstr)
   Google Scholar
• Drappa J., Brot N., Elkon K.B. The Fas protein is expressed at high levels on CD4+ CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 1993; 90: 10340–10344
   PubMed Web of Science ®Google Scholar
• Miyawaki T., Uehara T., Nibu R., Tsuji T., Yachie A., Yonehara S., Taniguchi N. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 1992; 149: 3753–3758
   PubMed Web of Science ®Google Scholar
• Robertson M.J., Manley T.J., Pichert G., Ritz J. Expression and function of APO-1/Fas (CD95) antigen on normal human lymphocytes. Leukocyte Typing V: White Cell Differentiation Antigens, S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Kishimoto, C. Morimoto, J. Ritz, S. Shaw, R.L. Silverstein, T.A. Springer, T.F. Tedder, R.F. Todd. Oxford University Press, Oxford 1994, (In press)
   Google Scholar
• Wesselborg S., Janssen O., Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral bloodT cells. J. Immunol. 1993; 150: 4338–4345
   PubMed Web of Science ®Google Scholar
• Alcover A., Weiss M.J., Daley J.F., Reinherz E.L. The Tl 1 glycoprotein is functionally linked to a calcium channel in precursor and mature T-lineage cells. Proc. Natl Acad. Sci. USA 1986; 83: 2614–2618
   PubMed Web of Science ®Google Scholar
• Cassatella M.A., Anegon I., Cuturi M.C., Griskey P., Trinchieri G., Perussia B. FcγR (CD 16) interaction with ligand induces Ca2+ mobilization and phosphoinositide turnover in human natural killer cells: role of Ca2+ in FcγR(CD16)-induced transcription and expression of lymphokine genes. J. Exp. Med. 1989; 169: 549–567
   PubMed Web of Science ®Google Scholar
• Vivier E., Morin P.M., O'Brien C., Schlossman S.F., Anderson P. CD2 is functionally linked to the α-natural killer receptor complex. Eur. J. Immunol. 1991; 21: 1077–1080
   PubMed Web of Science ®Google Scholar
• Vivier E., Morin P., O'Brien C., Drucker B., Schlossman S.F., Anderson P. Tyrosine phosphorylation of the Fc γ RIII (CD16): complex in human natural killer cells: induction by antibody dependent cytotoxicity but not by natural killing. J. Immunol. 1991; 146: 206–210
   PubMed Web of Science ®Google Scholar
• Moller P., Henne C., Leithauser F., Eichelmann A., Schmidt A., Bruderlein S., Dein J., Krammer P.H. Coregulation of the APO-1 antigen with intercellular adhesion molecule-1 (CD54) in tonsillar B cells and coordinate expression in follicular center B cells and in follicle center and mediastinal B cell lymphomas. Blood 1993; 81: 2067–2075
   PubMed Web of Science ®Google Scholar
• Sugarman B.J., Aggarwal B.B., Hass P.E., Figari I.S., Palladino M.A., Jr, Shepard H.M. Recombinant tumor necrosis factor-α effects on proliferation of normal and transformed cells in vitro. Science 1985; 230: 943–945
   PubMed Web of Science ®Google Scholar
• Larrick J.W., Wright S.C. Cytotoxic mechanism of tumor necrosis factor-α. FASEB J. 1990; 4: 3215–3223
   PubMed Web of Science ®Google Scholar
• Scheurich P., Thoma B., Ucer U., Pfizenmaier K. Immunoregulatory activity of recombinant tumor necrosis factor (TNF)-α induction of TNF receptors on human T cells and TNF-α-mediated enhancement of T cell responses. J. Immunol. 1987; 138: 1786–1790
   PubMed Web of Science ®Google Scholar
• Yokota S., Geppert T.D., Lipsky P.E. Enhancement of antigen-and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-a. J. Immunol. 1988; 140: 531–536
   PubMed Web of Science ®Google Scholar
• Kehrl J.H., Miller A., Fauci A.S. Effect of tumor necrosis factor α on mitogen-activated human B cells. J. Exp. Med. 1987; 166: 786–791
   PubMed Web of Science ®Google Scholar
• Erikstein B.K., Smeland E.B., Blomhoff H.K., Funderud S., Prydz K., Lesslauer W., Espevik T. Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur. J. Immunol. 1991; 21: 1033–1037
   PubMed Web of Science ®Google Scholar
• Naume B., Shalaby R., Lesslauer W., Espevik T. Involvement of the 55-and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. J. Immunol. 1991; 146: 3045–3048
   PubMed Web of Science ®Google Scholar
• Hollenbaugh D., Grosmaire L.S., Kullas C.D., Chalupny N.J., Braesch-Andersen S., Noelle R.J., Stamenkovic I., Ledbetter J.A., Aruffo A. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of asoluble form of gp39 with B cell co-stimulatory activity. EMBOJ. 1992; 11: 4313–4321
   PubMed Web of Science ®Google Scholar
• Liu Y.-J., Joshua D.E., Williams G.T., Smith C.A., Gordon J., MacLennan I. C. M. Mechanism of antigen-driven selection in germinal centres. Nature 1989; 342: 929–931
   PubMed Web of Science ®Google Scholar
• Van Lier R. A. W., Borst J., Vroom T.M., Klein H., Van Mourik P., Zeijlemaker W.P., Melief C. J. M. Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J. Immunol. 1987; 139: 1589–1596
   PubMed Web of Science ®Google Scholar
• Goodwin R.G., Alderson M.R., Smith C.A., Armitage R.J., Van den Bos T., Jerzy R., Tough T.W., Schoenborn M.A., Davis-Smith T., Hennen K., Falk B., Cosman D., Baker E., Sutherland G.R., Grabstein K.H., Farrah T., Giri J.G., Beckmann M.P. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell 1993; 73: 447–456
   PubMed Web of Science ®Google Scholar
• Smith C.A., Gruss H.-J., Davis T., Anderson D., Farrah T., Baker E., Sutherland G.R., Brannan C.I., Copeland N.G., Jenkins N.A., Grabstein K.H., Gliniak B., McAlister I.B., Fanslow W., Alderson M., Falk B., Gimpel S., Gillis S., Din W.S., Goodwin R.G., Armitage R.J. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73: 1349–1360
   PubMed Web of Science ®Google Scholar
• Shi Y., Glynn J.M., Guilbert L.J., Cotter T.G., Bissonette R.P., Green D.R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 1992; 257: 212–214
   PubMed Web of Science ®Google Scholar
• Colotta F., Polentarutti N., Sironi M., Mantovani A. Expression and involvement of c-fos, c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem. 1992; 267: 18278–18283
   PubMed Web of Science ®Google Scholar
• Itoh N., Nagata S. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. Biol. Chem. 1993; 268: 10932–10937
   PubMed Web of Science ®Google Scholar
• Mapara M.Y., Bargou R., Zugck C., Dohner H., Ustaoglu F., Jonker R.R., Krammer P.H., Dorken B. APO-1 mediated apoptosis or proliferation in human chronic B cell lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 1993; 23: 702–708
   PubMed Web of Science ®Google Scholar
• Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; IS: 1169–1178
   Web of Science ®Google Scholar
• Debatin K.-M., Goldman C.K., Waldmann T.A., Krammer P.H. APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 1993; 81: 2972–2977
   PubMed Web of Science ®Google Scholar
• Cohen P.L., Eisenberg R.A. Lpr, gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Anna. Rev. Immunol. 1991; 9: 243–269
   PubMed Web of Science ®Google Scholar
• Itoh N., Tsujimoto Y., Nagata S. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 1993; 151: 621–627
   PubMed Web of Science ®Google Scholar